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DOI 10.1016/j.stem.2011.06.002SUMMARY phenotype largely bereft of differentiation marker expression.Human embryonic stem cells (hESCs) expressing
pluripotency markers are assumed to possess equi-
potent developmental potential. However, disparate
responses to differentiation stimuli functionally illus-
trate that hESCs generate a spectrum of differenti-
ated cell types, suggestive of lineage bias. Here, we
reveal specific cell surface markers that allow sub-
fractionation of hESCs expressing hallmark markers
of pluripotency. By direct de novo isolation of
these subsets, we demonstrate that propensities
for lineage differentiation are balanced with reduced
clonogenic self-renewal. Histone modification marks
of gene loci associated with pluripotency versus
lineage specificity predicted cell fate potential of
these subfractions, thereby supporting the absence
of uniform bivalency as a molecular paradigm to
describe cell fate determination of pluripotent cells.
Our study reveals that cell fate potential is encoded
within cells comprising hESC cultures, highlighting
them as a means to understand the mechanisms of
lineage specification of pluripotent cells.
INTRODUCTION
The self-renewal and differentiation conditions deployed for
embryonic stem cell (ESC) propagation have traditionally
assumed that a homogeneous population of cells is present
within the culture. Recent studies have challenged this dogma,
indicating that ESC cultures are heterogeneous with individual
cells displaying dynamic phenotypes (Hayashi et al., 2008; Stew-
art et al., 2006). In addition to phenotype, heterogeneity occurs
at the level of ESC state, notablymanifested in the routine culture
of ESCs where cell-to-cell variance in the levels of pluripotency-
associated transcription factors like Nanog, Stella, and Rex1 can
be observed despite the maintenance of consistent levels of
other pluripotency markers, e.g., Oct4 (Chambers et al., 2007;
Hayashi et al., 2008; Toyooka et al., 2008). The presence of
Rex1 and Oct4 expression is a prerequisite for ESC contribution
in chimeric animal assays and describes an inner cell mass24 Cell Stem Cell 9, 24–36, July 8, 2011 ª2011 Elsevier Inc.ESCs lacking Rex1, but expressing Oct4, do not contribute to
the same chimera assays and express markers of the epiblast
(Toyooka et al., 2008). Such observations have illuminated the
diversity present within ESC populations and have contested
the preconception that expression of pluripotent markers is
a molecular and cell fate surrogate of homogeneous pluripotent
potential. As such, whether heterogeneity affects self-renewal of
human pluripotent stem cells (hPSCs) or developmental poten-
tial remains to be determined.
Despite the use of directed differentiation protocols, stimula-
tion of hESCs generates a spectrum of differentiated cell types
(D’Amour et al., 2006; Lee et al., 2007). This overall result under-
scores the low efficiency and yield of potentially therapeutically
useful cell types for cell replacement therapies or in vitro drug
interaction studies. Surprisingly, the mechanism behind this
phenomenon has received little attention, but the apparent pres-
ence of competing histone modifications at genes that are
known to influence lineage decisions may provide a rationale
for understanding the propensity of ESC cultures to differentiate
precociously (Mikkelsen et al., 2007). Chromatin modifications
are pivotal in the transmission of cell fate information during
stem cell proliferation and differentiation (Kouzarides, 2007;
Surani et al., 2007). Activating (H3K4me3) and repressive
(H3K27me3) histone methylations are associated with the tran-
scription and repression of gene expression, respectively (Kou-
zarides, 2007). Recent studies have demonstrated that both
human and mouse ESCs display notably high levels of concom-
itant H3K4me3 and H3K27me3 modifications, termed bivalent
domains, at lineage-specific gene loci (Bernstein et al., 2006).
These bivalent marks are reasoned to poise ESCs for fate spec-
ification (Pietersen and van Lohuizen, 2008), despite the lack of
functional demonstrations to support this idea.
Here, we reveal that specific cell surface markers in stem cell
factor receptor (c-KIT) and A2B5 allow subfractionation of
hESCs expressing equivalent levels of Oct4 and Nanog. Direct
de novo isolation of these hESC subsets demonstrates propen-
sities for the hematopoietic and neural lineage differentiation that
were concomitant with reduced self-renewal ability. Histone
modification marks of gene loci associated with pluripotency
and lineage specificity strongly predicted cell fate potential.
Our results indicate that cell fate potential is encoded within
functionally heterogeneous hESCs, thereby providing a means
of better understanding the fundamental processes that underlie
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specific differentiation from hPSCs.
RESULTS
Identification of Developmentally Distinct hESCs
Expressing c-KIT and A2B5
hESC culture conditions favor survival of self-renewing
cells (Thomson et al., 1998; Xu et al., 2001). Using immunohisto-
chemistry screens, we detected two markers, c-KIT and A2B5,
previously associated with mesoderm progenitors and neural
precursors, respectively (Carpenter et al., 2001; Yang et al.,
2008). Cells expressing c-KIT were located within and outside
morphologically identified hESC colonies (Figure 1A), whereas
A2B5 expression was restricted to regions outside colonies
previously associated with supportive cells termed hESC-
derived ‘‘fibroblasts’’ (hdFs) (Figure 1B). These subfractions
were present in four independent hESC lines (Figures S1A and
S1B available online). In addition to feeder-free systems, we
examined the expression of c-KIT and A2B5 in hESCs cocultured
with irradiatedmouse embryonic fibroblasts (MEFs). The location
of c-KIT and A2B5 was conserved and consistently observed in
multiple hESC lines cocultured on MEFs (Figures S1C–S1F).
These observations suggest that expression of c-KIT and A2B5
is generalizable to self-renewing cultures of hESCs independent
of growth conditions or hESC cell line.
To quantify this observation, flow cytometry analysis was
used; hESC cultures revealed a composition of 35% c-KIT+,
10% A2B5+, and 50% c-KIT/A2B5 cells (Figure 1C). A small
fraction (5%) of cells stained positive for both c-KIT and A2B5
(Figure 1C) and was strictly localized to the periphery of hESC
colonies, potentially representing a dynamic transient state of
primitive to lineage-primed cells (Figure S1D). We next examined
coexpression of pluripotency markers Oct4 and SSEA3 in the
c-KIT and A2B5 positive subfractions identified. Oct4 and
SSEA3 positive cells were equally distributed in c-KIT+ and
c-KIT subfractions (Figures 1D and 1E, respectively), whereas
Oct4 and SSEA3 negative cells were highly enriched with
c-KIT as compared with the c-KIT+ subfraction (Figures 1D
and 1E). The vast majority of Oct4 and SSEA3 positive cells
were observed in A2B5 hESCs (Figures 1F and 1G), and Oct4
and SSEA3 negative cells were predominantly found in A2B5+
hESCs (Figures 1F and 1G). These data indicate that cells ex-
pressing pluripotent-associated markers Oct4 and SSEA3 exist
at various frequencies among subfractions of c-kIT+/ and
A2B5+/ cells identified, thus revealing a previously unappreci-
ated level of underlying heterogeneity among hESCs.
Fractionated hESC Subpopulations Posses Clonogenic
Self-Renewal Capacity at Distinct Frequencies
To determine developmental potential among hESCs expressing
or lacking c-KIT and A2B5 in hESC cultures, cultures of hESCs
were stained with c-KIT or A2B5 antibodies conjugated to fluro-
chromes to enable direct isolation by fluorescence-activated cell
sorting (FACS) (Figures 2A and 2B). The self-renewal potential of
purified subfractions was analyzed in a quantitative hESC-CIC
(colony-initiating cell) assay by replating single cells in feeder-
free hESC culture conditions as shown previously (Bendall
et al., 2007; Stewart et al., 2008). Clonogenic regenerationcapacity was equivalent among KIT+ versus KIT hESCs (7.5
and 8 per 5000 cells, respectively), whereas the subfraction
devoid of A2B5 expression was enriched for clonogenic ability
at 23 colonies per 5000 cells, and A2B5 expressing hESC sub-
fractions contained clonogenic self-renewal ability at 2 colonies
for 5000 (Figure 2C).
Although the relative frequencies of hESC-CIC residing in
these four subfractions of hESCs can be measured and
compared, the quality and composition of individual colonies
derived from hESC-CIC of each fraction requires further exami-
nation at the individual colony level independent of frequency.
Accordingly, we performed live staining on emerging colonies
using montage confocal imaging of individual wells seeded
with single cells from all four hESC subfractions. At Day 6 after
single cell plating, cultures were stained with the antibody
against the pluripotency marker Tra 1-60, and again via multipa-
rameter endpoint staining using Oct4, SSEA3, Hoechst, c-KIT,
and A2B5 at Day 15. Our results demonstrated that initiation of
compact pluripotent colonies from all the subfractions occurs
equally, indicating that differences in CIC frequency (Figure 2C)
were not due to kinetics of CIC emergence or timing of colony
formation among these subfractions of hESCs (Figure 2D). In
addition to these static time points, this equality was confirmed
by time course imaging between Days 6 to 15 of colony emer-
gence, recorded every 8 hr for each of the four subfractions of
hESCs (data not shown). Based on Day 15 endpoint staining,
functionally defined clonogenic hESCs (Stewart et al., 2006)
were capable of reestablishing complete composition of hESC
cultures from which the subfractions were originally derived,
including those comprising hdFs and identical profiles of Oct4,
SSEA3, c-KIT, or A2B5 expresssion (Figures 2E and 2G; Fig-
ure S2). Furthermore, addition of chemical ROCK inhibitor, which
has been reported to increase cloning efficiency from unfrac-
tioned hESCs by increasing survival upon disaggregation and
subsequent replating (Watanabe et al., 2007), had no effect on
cloning efficiency of CICs generated or acquisition of pluripo-
tency markers on CICs using this assay (Figures S3A and
S3B). Although ROCK inhibitor provides a survival advantage
in the absence of a homologous niche support layer (Watanabe
et al., 2007), inhibition of the pathway has no augmenting effect
in our system of clonogenic readout (Stewart et al., 2006) that is
supplemented by hdF support.
c-KIT and A2B5 hESCs Posses Gradients
of Lineage-Specific Markers
To further examine the basis for coexpression of pluripotency
and lineage-specific markers of isolated hESC subsets, gene
expression analysis was performed by Q-RT-PCR. Oct4 and
Nanog transcripts were equivalently detected in c-KIT+ and
c-KIT fractions (Figure 3A), supportive of the flow cytometry
analysis (Figure 1D) and consistent with functional clonogenic
capacity (hESC-CICs) from these two subfractions of hESCs
(Figure 2C). Consistent with the presence of clonogenic self-
renewing capacity from both A2B5+ and A2B5 cells, both sub-
fractions expressed Oct and Nanog; however, the A2B5 hESCs
expressed 25- to 35-fold higher levels of both compared with
those of the A2B5+ fraction (Figure 3B). To determine whether
c-KIT or A2B5 expression on hESCs affected lineage propensity
toward mesoderm or neural fates, we assessed transcript levelsCell Stem Cell 9, 24–36, July 8, 2011 ª2011 Elsevier Inc. 25
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Figure 1. Distribution of c-KIT and A2B5 in Undifferentiated hESCs
(A and B) Immunocytochemistry staining for c-KIT (A, green) and A2B5 (B, green) costained with Oct4 (red) in feeder-free H1 cultures. Nuclei were counterstained
with 4,6-diamidino-2-phenylindole (DAPI, blue). Scale bar, 100 mm. hdFs, hESC-derived fibroblast-like cells.
(C) Percentages of c-KIT and A2B5 costained cells in H1 cultures by flow cytometry.
(D–G) H1 cultures were costained with c-KIT-Oct4, A2B5-Oct4, c-KIT-SSEA3, and A2B5-SSEA3. Bar graphs indicate percentage of cells positive/negative for
abovementioned markers.
See also Figure S1.
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Encoded Human PSC Fateof lineage-associated genes: Brachyury and MIXL1 for meso-
derm (Ng et al., 2005; Vijayaragavan et al., 2009), and Pax6
and NF-68 for neural (Itskovitz-Eldor et al., 2000; Wu et al.,
2007) lineages. Transcript levels for Brachyury and MIXL1
showed an approximately 2-fold increase in c-KIT+ cells
compared with expression levels in c-KIT cells (Figure 3C).26 Cell Stem Cell 9, 24–36, July 8, 2011 ª2011 Elsevier Inc.Similarly, both neural genes Pax6 and NF-68 were expressed
at higher levels in the A2B5+ fraction than in the A2B5 fraction
of hESCs (Figure 3D). To verify whether the transcript expression
of these lineage-associated genes correlated with protein in
these subfractions of hESCs, we used Brachyury (a surrogate
mesodermal marker) to validate this via intracellular staining.
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Figure 2. Differential Clonogenic Capacities
of c-KIT+/– and A2B5+/– Populations
(A and B) Representative FACS plots based on
expression of c-KIT (A) and A2B5 (B) in feeder-free
hESC cultures. Sort gate and postsort purity are
shown. (C) Frequencies shown in top histograms
indicate the average and standard deviation from
four independent experiments. (D) Quantitative
clonogenic assay. For CIC assay, cells with
>99.0% purity were seeded on irradiated hdFs
(20,000 cells per well). Shown are representative
images of colonies formed from sorted c-KIT+/
and A2B5+/ cells live stained with Tra 1-60. (D and
E) Regenerated colonies were enumerated at
postseed Day 14. Scale bars, 100 mm. Clonogenic
output from c-KIT+/ (E) and A2B5+/ populations
was stained with Oct4, SSEA3, and Hoechst
staining. (F) Enlarged images of Oct4, SSEA3, and
Hoechst staining. Circled areas in the brightfield
and stained images are enlarged images. See also
Figures S2 and S3.
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Encoded Human PSC FateThe c-KIT+ hESC subfraction contained 3- to 4-fold greater
amounts of Brachyury positive cells, consistent with meso-
dermal predisposition, compared with amounts of c-KIT hESCs
and A2B5+ cells (Figures 3E and 3F). Collectively, these results
demonstrate that a gradient of clonogenic self-renewal exists
among hESC cultures that can be further characterized by
a combination of lineage-associated and pluripotent markers.
c-KIT+ and A2B5+ hESCs Are Predisposed
for Lineage-Specific Differentiation
Using the well-characterized hematopoietic lineage as an
example of mesodermal potential (Chadwick et al., 2003;
Vijayaragavan et al., 2009), we fractionated c-KIT+ and c-KIT
subpopulations and assayed them for embryoid body (EB)-
derived hematopoietic development using Re-Aggregated-
Embryoid Bodies (RA-EBs) from FACS-isolated hESC-derived
populations (Figure S4). This direct isolation into differentiation
conditions prevents reculturing of isolated hESC subsets that
reset pluripotent state and hESC culture heterogeneity, asCell Stem Cell 9,shown in Figure 2 and Figure S3. RA-EBs
were successfully formed from isolated
c-KIT+ and c-KIT cells and cultured in
hematopoietic-inducing conditions for
15 days (Figure 4A). During EB hemato-
poietic development, both c-KIT+ and
c-KIT RA-EBs showed no significant
differences in diameter and viability
(Figures 4B and 4C). As previously char-
acterized, the hematopoietic develop-
ment from hESCs can be divided into
two phases: bipotent hemogenic-speci-
fied phase (Days 0 to 7), and hematopoi-
etic committed phase (Days 7 to 15)
(Vijayaragavan et al., 2009; Wang et al.,
2004) (Figure 4D). The frequencies of
hemogenic precursors, primitive hemato-
poietic progenitors, and mature hemato-poietic cells were significantly enhanced in c-KIT+ RA-EBs
compared with c-KIT RA-EBs (Figure 4E). These data indicate
a predisposition of c-KIT+ hESCs to give rise to mesodermal
development, distinctly from remaining hESCs.
To further explore the potential differentiation bias of hESCs,
we also formed RA-EBs from A2B5+ and A2B5 hESCs. RA-EBs
from the A2B5+ cells preferentially differentiated into neural line-
ages, producing extensive neurite-like outgrowths when plated
back onto a fibronectin growth substrate (Figure 5A). However,
the A2B5 hESCs displayed extremely low viability (5.1%)
upon isolation (Figure 5B), and in contrast to A2B5+ hESCs, failed
to form RA-EBs, thereby preventing side-by-side comparison of
neural differentiation capacity with A2B5+ hESCs (Figures 5A–
5C). This inability for A2B5 hESCs to form EBs raised the possi-
bility of a unique relationship between A2B5 and A2B5+ cells for
lineage development. To explore this idea, we prospectively iso-
lated A2B5+ and A2B5 subpopulations from either GFP+ or
RFP+ marked hESC lines. A2B5+GFP+ cells were then mixed
with A2B5RFP+ cells, or in the reverse case, A2B5GFP+ cells24–36, July 8, 2011 ª2011 Elsevier Inc. 27
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Figure 3. c-KIT and A2B5 Subfractions Posses Gradients of Pluripotent and Lineage-Specific Markers
(A and B) Quantitative PCR analysis for Oct4 and Nanog expression in sorted c-KIT+/ and A2B5+/ populations. The mean expression normalized against
GAPDH is shown.
(C and D) Quantitative PCR analysis for Brachyury and MIXL1 in sorted c-KIT+ and c-KIT populations. The mean expression normalized against GAPDH is
shown.
(E and F) H1 cultures were stained with either c-KIT and Brachyury or with A2B5 and Brachyury and results were analyzed by flow cytometry analysis. Bar graphs
indicate frequency of c-KIT/Brachyury and A2B5/Brachyury costained cells.
See also Table S1.
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Encoded Human PSC Fatewere mixed with the A2B5+RFP+ subfractions (Figure 5D). Using
these mixtures, RA-EBs were successfully formed from both
combinations (Figures 5E and 5F). Under culture conditions
conducive to neural differentiation, A2B5+ cells (green in Fig-
ure 5E, red in Figure 5F) were present in greater numbers than
A2B5 cells (red in Figure 5E, green in Figure 5F). Notably, higher
frequencies of neural lineage markers—such as A2B5; glial fibril-
lary acidic protein (GFAP), indicative of astrocytes (Shin et al.,
2006); and microtubule-associated protein 2 (MAP2), indicating
neurons (Jang et al., 2010)—were observed in A2B5+ RA-EBs
(80.3%, 68.2%, and 71.1%) at greater rates than were observed
in A2B5 RA-EBs (11.5%, 13.4%, and 14.5%) (Figures 5G and
5H; Figure S5). Total frequencies of neural lineage markers and
the proportion of GFP+ to RFP+ cells in RA-EBs at Day 9 of neural28 Cell Stem Cell 9, 24–36, July 8, 2011 ª2011 Elsevier Inc.differentiation are shown in Figures 4G and 4H, indicating that
these effects were not related to the use of either GFP or RFP
cell lines. These results indicate that A2B5+ hESCs have
a propensity for neural development, but also are capable of
rescuing survival and neural capacity of purified A2B5 hESCs
incapable of participating in EB development alone.
Overall, these studies demonstrate that c-KIT+ and A2B5+
hESCs are lineage-biased toward hematopoietic and neural
cell fate, respectively. In addition, our observations demonstrate
that a functional dependency among subfractions within hESC
cultures extends beyond niche requirements to support hESC
self-renewal (Bendall et al., 2007, 2008; Stewart et al., 2008),
but is equally critical for lineage development in the case of
neural differentiation shown here.
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Figure 4. Hematopoietic Differentiation Potentials of c-KIT+ and c-KIT– Populations
(A) Hematopoietic differentiation of c-KIT+/ cells using RA-EB assay. RA-EB images at different stages of hematopoietic differentiation (arrowheads indicate Day
4 reaggregates formed from sorted c-KIT+/ cells) are shown. Scale bars, 100 mm.
(B) Relative diameter of Day 4 RA-EBs.
(C) Viability in Day 15 RA-EBs.
(D and E) Schematic diagram of hematopoietic development from hESCs. Flow cytometric analysis of Day 15 RA-EBs for hemogenic precursors (CD45negPFV)
and committed hematopoietic (CD45+CD34+ and CD45+CD34) cells. All bars indicate the average and standard deviation of three independent experiments.
**p < 0.01.
See also Figure S4.
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Encoded Human PSC Fatec-KIT+ and A2B5+ hESCs Are Epigenetically Primed
for Differentiation
To determine the molecular basis for functional predisposition of
c-KIT or A2B5 hESC subsets to differentiation toward a hemato-poietic or neural cell fate, we investigated whether there is an
epigenetic mechanism underlying these lineage biases. As
shown previously (Pan et al., 2007), using antibodies against
H3K4me3 and H3K27me3, we found extensive enrichment ofCell Stem Cell 9, 24–36, July 8, 2011 ª2011 Elsevier Inc. 29
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Figure 6. Comparison of Histone Modification between UF hESC Cultures and Isolated Subpopulations
(A–C) Single ChIP analysis of histone modification on pluripotency genes (A, Oct4 and Nanog), mesodermal lineage genes (B, Brachyury, MIXL1, Meox1, Tbx6,
and Eomes), and neural lineage genes (C, Pax6, NF-68, Mash1, Sox1, and Nestin) loci in UF hESC cultures.
(D and E) Sequential ChIP (anti-H3K4me3 ChIP followed by anti-H3K27me3 ChIP) analysis of histone modification on Oct4 and Nanog loci in isolated c-KIT+/
(D) and A2B5+/ (E) populations.
(F–H) Sequential ChIP analysis of histone modification on mesodermal and neural loci in UF hESC cultures and isolated c-KIT+/ and isolated A2B5+/ pop-
ulations. Histone modification states of target loci were determined by ChIP and quantitative PCR in H1 and H9 hESCs. The error bars indicate SD of three
independent experiments. *p < 0.05; **p < 0.01. UF, unfractionated culture; K4, H3K4me3; K27, H3K27me3; Act, activation; Biv, bivalency. (H and I) Sequential
ChIP analysis of histone modification on additional mesodermal and neural genes in isolated c-KIT+/ and A2B5+/ populations.
See also Figures S6 and Table S2.
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Encoded Human PSC FateH3K4me3 activation marks on the Oct4 and Nanog loci in
unfractionated (UF) hESC cultures (Figure 6A). Consistent with
previous reports (Bernstein et al., 2006; Boyer et al., 2006; Pan
et al., 2007; Surface et al., 2010; Zhao et al., 2007), gene loci
associated with mesodermal (Brachyury, MIXL1, Meox1,
Eomes, and Tbx6) and neural (Pax6, NF-68, Mash1, Nestin,Figure 5. Neural Differentiation Potentials of A2B5+ and A2B5– Popula
(A) Neural differentiation of isolated A2B5+/ cells. While A2B5+ cells generated R
fibronectin-coated growth surface, A2B5 cells failed to form RA-EBs (B). Scale b
are shown. ND, not detected. (D) Representative FACS plot of A2B5+/ fractions is
each population were reaggregated together as follows: A2B5+GFP+ and A2B5R
neural differentiation of reaggregates of A2B5+GFP+ and A2B5RFP+ or A2B5
frequencies of neural lineagemarkers (A2B5, GFAP, andMAP2) at Day 9 of neural
deviation from three independent experiments. Scale bars, 100 mm. *p < 0.05; **and Sox1) lineages showed a bivalent pattern (Biv) for
H3K4me3 activation and the H3K27me3 repression marks in
UF hESC cultures (Figures 6B and 6C). In total, these observa-
tions are similar to those in previous reports describing that
H3K4me3 activationmarks are primarily associated with pluripo-
tency markers, and bivalent marks are typically observed attions
A-EBs and then neuronal-like cells (arrowhead) when subsequently plated onto
ars, 100 mm. Viability (C) and A2B5 expression at Day 9 of neural differentiation
olated fromGFP and RFP transduced hESC lines. Mixtures of 100,000 cells for
FP+ or A2B5GFP+ and A2B5+RFP+. (E and F) Fluorescent RA-EB images and
GFP+ and A2B5+RFP+ are shown. (G and H) Total percentages and relative
differentiation in fluorescent RA-EBs. All bars indicate the average and standard
p < 0.01. See also Figure S5.
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Encoded Human PSC Fatedevelopmental gene loci for hESCs (Bernstein et al., 2006; Pan
et al., 2007; Zhao et al., 2007).
Based on functional lineage and clonogenic self-renewal bias
among c-KIT+/ and A2B5+/ subsets of hESCs, using sequen-
tial ChIP methods (Bernstein et al., 2006) we examined the
relative enrichment of H3K4me3 (first ChIP) and H3K27me3
(second ChIP) on the Oct4 and Nanog loci in c-KIT+/ and
A2B5+/ subfractions of hESCs (Figures 6D and 6E). We
observed low levels of H3K27me3 enrichment, which is indica-
tive of gene activation at the Oct4 locus in c-KIT+, c-KIT, and
A2B5 subfractions (Figures 6D and 6E), a result in accordance
with flow cytometry analysis (Figures 1D and 1E) and Oct4 tran-
script expression (Figures 3A and 3B). Oct4 and Nanog were
activated in all fractions of hESCs (Figures 6D and 6E); however,
A2B5+ hESCs showed low levels of H3K4me3 enrichment at the
Oct4 locus (Figure 6E), compared to other subsets. To explore
lineage-specific loci, we next examined the relative enrichment
of H3K4me3 and H3K27me3 on the 50 regions of mesoderm
lineage-associated genes—Brachyury, MIXL1, Meox1, Eomes,
and Tbx6—in c-KIT+ and c-KIT hESCs. We observed extensive
enrichment of H3K4me3 on these loci in c-KIT+ hESCs, while
enrichment of H3K27me3 was displayed in c-KIT hESCs (Fig-
ure 6F). When these same subpopulations of hESCs were
analyzed for the chromatin state of neural associated gene
loci, such as Pax6 and NF-68, we observed chromatin marks
indicative of repression (Figure 6G). Activated marks on these
loci in c-KIT+ hESCs correlate with the increased expression of
Brachyury and MIXL1 genes observed by transcript measure-
ment and flow cytometry analysis and functionally demonstrated
by more permissive hematopoietic developmental potential
(Figures 3C and 3E and Figure 4).
Based on these observations, we extended our analysis to
neural-associated Pax6, NF-68, Mash1, Nestin, and Sox1 loci
in A2B5+ and A2B5 hESCs. Bivalent domains were observed
for all above loci in both UF cells (Figure 6C). However, sequen-
tial ChIP analysis identified loss of H3K27me3 on these loci in
A2B5+ hESCs when compared with the UF or A2B5 subfrac-
tions (Figure 6H). Similar to correlations of histone marks and
gene transcription, these observations are consistent with
gene expression levels of Pax6 and NF-68 in A2B5+ hESCs (Fig-
ure 3D). On the contrary, analysis of mesodermal associated
gene loci (Brachyury and MIXL1) in A2B5 hESC subsets
showed reduced activation (Figure 6I). Control experimentation
using fibroblasts showed substantial levels of H3K27me3marks,
but negligible H3K4me3 marks (Figure S6), and identical results
were generated using these lineage-specific genes using
reversed sequential ChIPs (e.g., H3K27me3 first ChIP followed
by H3K4me3 second ChIP, data not shown). These resultsFigure 7. Proposed Model
(A) Single ChIP analysis of histone modification on pluripotency genes (A, Oct4 a
lineage genes (C, Pax6 and NF-68) loci in c-KITA2B5 hESC cultures. (B) Sequ
histonemodification on pluripotency,mesodermal loci, and neural loci in UF hESC
use UF cultures of hESCs. Accordingly, the experimental evidence from UF hES
clonogenicity and specification, which is manifest as expression of pluripotent m
associated genes. (E) When hESC culture heterogeneity is deconstructed by frac
associated gene loci are resolved down to activating monovalent histone mark
monovalent epigenetic marks at lineage-associated gene loci now provide a preprovide confirmation of the unique profile of activation and
repression domains within these subfractions of hESCs.
Of all cells comprising hESC cultures, nearly 50% are devoid
of both c-KIT and A2B5 expression (Figure 1C). Based on the
monovalent encoded chromatin marks revealed in subsets of
c-KIT+ and A2B5+ hESCs, we sought to evaluate the chromatin
state within the subset of c-KITA2B5 hESCs most likely to
harbor bivalent chromatin marks due to the absence of
lineage-associated protein expression (Figure 1C). Oct4 and
Nanog gene loci showed extensive enrichment of H3K4me3
marks (indicative of activation) in c-KITA2B5 hESCs (Fig-
ure 7A). Unlike bivalent domains observed in UF hESCs (Fig-
ure 6A and 6C), strong enrichment of H3K27me3 marks (indica-
tive of repression) was revealed on mesodermal-associated loci
(Figure 7B) and neural-associated loci (Figure 7C). These results
were consistent for all loci analyzed by sequential ChIP assays
(IP H3K27me3; Re-IP-H3K4me3) for purified c-KITA2B5
hESCs, confirming our inability to detect bivalent marks in all
subfractions analyzed, in contrast to analysis performed on UF
hESC cultures.
Taken together, these studies suggest that biased lineage
developmental potential of hESC subfractions is encoded by
histone modifications of H3K27me3 and H3K4me3 methylation
found at lineage-associated and pluripotency genes. In addition,
fractionation of previously unknown subpopulations of hESCs
resolves apparent bivalent histone methylation marks of UF
hESC cultures into monovalent signatures that can be correlated
to functional lineage potential via robust differentiation assays.
DISCUSSION
Our study describes a previously unappreciated level of con-
cealed developmental potential among hESCs that has direct
implications for the differentiation and cell fate decisions of
hESCs. Using c-KIT or A2B5 expression as examples, we delin-
eate that seemingly equivalent hESCs possess a relationship
between phenotypic heterogeneity and functional propensity
for self-renewal and differentiation programs that we reveal are
uniquely encoded by histone modifications of hESC subsets.
Pluripotency-associated cell surface markers such as SSEA3,
GCTM-2, and CD9 allow isolation of subpopulations of cells from
hESC cultures that display high levels of pluripotency gene tran-
scripts (Enver et al., 2005; Hough et al., 2009; Stewart et al.,
2006). These studies established that heterogeneity is typical
in hESC cultures, but did not elucidate the identity and functional
capabilities of these hESC compartments. The combined anal-
ysis and correlation of c-KIT+ or A2B5+ subfractions, expression
profiling, and lineage potential measured by the RA-EB assaysnd Nanog), mesodermal lineage genes (B, Brachyury and MIXL1), and neural
ential ChIP (anti-H3K27me3 ChIP followed by anti-H3K4me3 ChIP) analysis of
cultures and isolated c-KITA2B5 populations. (D) Current reports exclusively
C cultures suggests that the undifferentiated cells ‘‘straddle’’ the boundary of
arkers but concomitant bivalent H3K27me3 and H3K4me3 marks at lineage-
tionating the cultures, previously described bivalent histone marks at lineage-
s and a plastic gradient of clonogenicity and specification is revealed. These
dictive index of eventual cell fate progression. See also Table S2.
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Encoded Human PSC Fateillustrates that hESC cultures are a complex mosaic of cell types
that cover the spectrum from self-renewing undifferentiated
stem cells to incipient lineage-biased cells.
The accession of lineage markers is typically associated with
the loss of pluripotency markers (Hough et al., 2009; Toyooka
et al., 2008). Our data suggests that the mutually exclusive rela-
tionship often described between pluripotency and fate markers
is not always maintained. Although A2B5+ hESCs showed
marked downregulation of pluripotencymarkers at both the tran-
script and protein levels, they expressed these proteins and
were capable of clonogenic self-renewal capacity. For c-KIT+
hESCs there was little change in Oct4 and Nanog levels, and plu-
ripotencymarker SSEA3was equally distributed in c-KIT+ versus
c-KIT populations of hESCs. The functional validation of these
results by the hESC-CIC assay demonstrated that the c-KIT+,
c-KIT and A2B5+, A2B5 subpopulations of hESCs are all
similar in their ability to reinitiate hESC colonies and cultures,
but vary in frequency of clonogenic self-renewal cells.
Several reports describe the epigenetic modification patterns
present within ESCs that are thought to control pluripotency and
cell fate specification (Azuara et al., 2006; Bernstein et al., 2006;
Boyer et al., 2006; Pan et al., 2007; Zhao et al., 2007). Concom-
itant H3K4me3 (activating) and H3K27me3 (repressive) methyla-
tion patterns mark untranscribed lineage-specific gene loci,
termed bivalent domains. Our results are unique to the view
that describes hESCs as being concomitantly pluripotent and
primed for fate decisions by competing constellations of histone
modifications that position loci in a bivalent state (Figure 7D).
Alternatively, we posit that the phenomenon of histonemodifica-
tion bivalency is the direct result of collectively assaying a diverse
range of cell types resident within hESC cultures, suggesting that
bivalency reflects a population of hESCs with unequivalent
developmental potentials and not necessarily the state of indi-
vidual hPSCs. Our data demonstrated that bivalent domains
are detectable in UF hESC cultures. However, when the hESC
cultures are fractionated into mesoderm (c-KIT+) or neural
(A2B5+) progenitors, the co-occupancy of H3K27me3 and
H3K4me3 marks at mesoderm- or neural-related gene loci is
reduced to a monovalent activation or repression methylation
signature. Moreover, the epigenetic signature at the mesoderm
or neural lineage genes that we assayed appears to be a direct
predictor of the fate attainable when the specific prospective
populations (c-KIT+/ or A2B5+/) are differentiated. Recent
studies have established that bivalent methylation patterns at
gene loci are not the norm in the frog embryo, and that genes
with associated bivalent domains are typically transcribed and
not repressed as posited in ESCs (Akkers et al., 2009). Based
on these results, we propose that when heterogeneity among
hESCs is deconstructed by fractionation, the overall state of
human pluripotency is best described as a plastic and dynamic
gradient of clonogenic and lineage specification potentials
(Figure 7E).
Our proposed model to describe hPSC state is further sup-
ported by a recent publication from Scholer et al. (Cherry and
Daley, 2010; Han et al., 2010) wherein mouse EpiSCs showed
a metastable subpopulation of cells that represent various
epiblast stages in vivo. Since human ESCs share basic similari-
ties with mouse EpiSCs, we believe that observed heterogeneity
is inherent to the cells of the epiblast stage. Human ESCs might34 Cell Stem Cell 9, 24–36, July 8, 2011 ª2011 Elsevier Inc.posses the intrinsic memory of the location and proximity to be
primed to differentiate in vitro, similar to that of the transient
epiblast cells. Nonetheless, recent studies demonstrated that
bFGF-responsive hESC cultures could be converted to mouse
ES-like LIF-dependent colonies by inhibition of multiple signaling
pathways, including GSK and ERK1/2, providing further
evidence of the intricate signaling that might be responsible for
observed priming of lineage potentials. Nevertheless, our study
reveals an unpredicted biodiversity within the undifferentiated
state, demonstrating monovalent epigenetic marks at lineage-
associated gene loci that provide an encoded predictive index
of eventual cell fate progression, thereby offering a unique
perspective for understanding the mechanisms of lineage spec-
ification from PSCs in the human.
EXPERIMENTAL PROCEDURES
hESC Culture
Undifferentiated hESC lines H1, H9, HES3, and CA2 were maintained in
feeder-free culture as previously described (Bendall et al., 2007). Briefly,
hESCs were cultured on Matrigel (BD Biosciences)-coated 6-well plates with
MEF-CM supplemented with 8 ng ml1 of bFGF (Invitrogen). In order to main-
tain undifferentiated state, MEF-CM was changed daily and hESCs were
passaged at a 1:2 split ratio every 6–7 days by enzymatic dissociation with
200 U ml1 collagenase IV (Invitrogen). hESC culture was carried out at
37C in humidified atmosphere containing 5% CO2. H1 and H9 hESC lines
were used for all experiments. H1, H9, HES3, and CA2 were used for immuno-
fluorescence and FACS analysis.
Flow Cytometry
Single-cell suspensions of undifferentiated hESCs were obtained by dissocia-
tion with TrypLE (Invitrogen) or collagenase IV at 37C. EBs were dissociated
with 0.4 U/ml collagenase B (Roche Diagnostics) for 2 hr in a 37C incubator,
followed by treatment with cell dissociation buffer (Invitrogen) for 10 min in
37C. They were passed through a 70 mm cell strainer (BD Biosciences). For
intracellular staining of Oct4 antibody, Cytofix/Cytoperm (BD Biosciences)
and Perm/Wash buffer (BD Biosciences) were used following the manufac-
turer’s instructions. The following primary and secondary antibodies were
used: mouse anti-Oct4 (BD Bioscience), mouse anti-CD117-allophycocyanin
(APC) (CALTAG), mouse anti-IGF1R-phycoerythrin (PE) (BD Biosciences),
mouse anti-A2B5 (R&D), mouse anti-GFAP (R&D), mouse anti-MAP2 (BD
Biosciences), rat anti-SSEA-3 (Developmental Studies Hybridoma Bank),
anti-Brachyury (Abcam), goat anti-mouse Alexa Fluor 488 (Invitrogen), and
goat anti-mouse Alexa Fluor 647 (Invitrogen). We used 7-amino actinomycin
(7-AAD, Immunotech) to eliminate dead cells. Surface marker expressions
were used using FACSCalibur (BDIS) and FlowJo software (Tree Star).
Immunocytochemical Analysis
hESCs cultured on MEFs or in Matrigel-coated 4-well chamber slides (Lab-
Tek) were rinsed three times before fixation with 4% paraformaldehyde in
PBS for 20 min and then permeablized with 0.5% saponin in PBS containing
1% BSA. Cells were blocked with 10% normal rabbit serum for 30 min at
room temperature. The following primary and secondary antibodies were
used: mouse anti-A2B5 (R&D), mouse anti-c-KIT (Santa Cruz Biotechnology),
goat anti-Oct3/4 (N19) (Santa Cruz Biotechnology), rat anti-HLA-A/B/C
(Abcam), rabbit anti-mouse Alexa Fluor 594 (Invitrogen), goat anti-mouse fluo-
rescein isothiocyanate (FITC) (Santa Cruz Biotechnology), goat anti-rat Alexa
Fluor 594 (Invitrogen), and rabbit anti-mouse FITC (Zymed). Primary and
secondary antibodies were diluted with PBS containing 10% rabbit or goat
serum. Primaries were incubated at 4C for 24 hr, and secondaries were incu-
bated at room temperature for 1 hr. Chamber slides were counterstained using
VECTASHIELD Mounting Medium with DAPI (Vector Labs) and examined
using an Olympus IX51 microscope. Fluorescence images were captured
with a Photometrix Cool Snap HQ2 camera using Image-Pro 3DA version
6.0. For live staining, Tra 1-60 antibody (anti-mouse IgM; Millipore) was
Cell Stem Cell
Encoded Human PSC Fateconjugated with secondary antibody (Alexa Fluor 647 goat anti-mouse IgM).
This preconjugated sterile antibody mix was added to the well containing
emerging CICs (6 days postseeding). Antibody was incubated with cells for
approximately 20–30 min. Culture medium was washed twice and cells were
visualized by Montage imaging system. Fluorescence images were captured
with a Photometrix Cool Snap HQ2 camera using Image-Pro 3DA version
6.0, Nikon Biostation CT, or Cellomics Arrayscan VTi.
hdFs Preparation
hdFs were prepared as previously described (Stewart et al., 2006). Briefly, we
treated hESC culture with collagenase IV for 10 min, removed the collagenase
IV, and then washed the wells with KO-DMEM (Invitrogen) to collect hdFs.
Supernatant containing the cells was centrifuged and the cell pellet was resus-
pended in MEF-CM supplemented with 8 ng ml1 bFGF. We transferred the
cells to fresh Matrigel-coated wells and changed the medium every other
day. The confluent hdFs were passaged in the same manner as for hESCs
and frozen in liquid nitrogen until use for clonogenic assay.
Reverse Transcription and Q-RT-PCR
Total RNA was extracted from sorted cells using Absolutely RNAmicroprep kit
(Stratagene). First strand cDNA was synthesized from 1 mg of total RNA and
then subjected to Q-RT-PCR using SYBR Green PCR Master Mix and RT-
PCR reagents (Applied Biosystems). Quantitative PCR was performed on an
Mx3000P qPCR system (Stratagene) using the following conditions: 95C for
10 min, followed by 40 cycles of 95C for 15 s, and 60C for 1 min. Specific
PCR products were detected by the fluorescence double strand DNA-binding
dye SYBRGreen. PCR amplification was performed in triplicate and replicated
in three independent experiments. The sequences of the primers are listed in
Table S1. Melting curve analyses were performed to confirm correct PCR
product size and absence of nonspecific bands. The expression levels of
each gene were normalized to GAPDH and the relative quantification was per-
formed using the comparative CT method according to the manufacturer’s
protocols (Applied Biosystems).
hESC Isolation and Clonogenic Assay
Undifferentiated hESCswere treatedwith TrypLE for 10min to dissociate them
into single cells and passed through a 70 mm cell strainer for hESC clonogenic
assays as shown previously (Bendall et al., 2007; Stewart et al., 2006) Single-
cell suspensions were stained for c-KIT and A2B5 as described above. We
selected c-KIT+/ and A2B5+/ subsets from live cells identified by 7-AAD
exclusion using FACSAria (BD PharMingen). For clonogenic assay, FACS iso-
lated cells were rinsed twice and centrifuged at 450 3 g for 5 min. The cell
pellet was resuspended in MEF-CM supplemented with 8 ng ml1 bFGF. For
quantitative analysis of CIC assay, we seeded 20,000 cells per well containing
Matrigel plus irradiated hdFs and changed the medium every other day. After
14 days, colonies were counted.
To assess the quality of the CIC-generated cells from individual subfrac-
tions, cells were seeded at following densities: cKit+, 40,000; cKit, 25,000;
A2B5+, 200,000; and cKit+, 10,000.
EB and RA-EB Formation
For hematopoietic differentiation using the clumps of hESC colonies, we
generated EBs by suspension culture methods as previously described (Cer-
dan et al., 2007). Briefly, on the day of passage, the confluent undifferentiated
hESCs were treated with 200 U ml1 collagenase IV for 5 min and then trans-
ferred to 6-well ultra low attachment (ULA) plate (Corning). These clumps were
incubated overnight to allow EB formation in EB medium consisting of
KO-DMEM supplemented with 20% non-heat-inactivated fetal bovine serum
(Hyclone), 1% nonessential amino acids, 1 mM L-Glutamine, and 0.1 mM
b-mercaptoethanol. For differentiation using sorted single-cell suspensions,
we generated EBs by forced aggregation. Sorted single-cell suspensions
were rinsed twice with PBS and then resuspended in EBmedium. Reaggrega-
tion was carried out by placing the defined number (200,000 cells) of sorted
single cells reconstituted with 150 ml of EB medium in 96-well round bottom
plates (NUNC). After distribution, we added 150 ml of 1:15 diluted Matrigel
into each well to improve adhesion between cells. The plates were centrifuged
at 450 3 g for 5 min and incubated overnight to allow reaggregation.Hematopoietic and Neural Differentiation
For hematopoietic differentiation, EBs generated using clumps and single cells
were transferred to newULA plates containing EBmedium supplemented with
hematopoietic growth factors (hGFs) as follows: 50 ng ml1 hG-CSF (Amgen),
300 ng ml1 hSCF (Amgen), 10 ng ml1 hIL-3 (R&D), 10 ng ml1 hIL-6 (R&D),
25 ng ml1 hBMP-4 (R&D), and 300 ng ml1 hFlt-3L (R&D). EBs were cultured
for 15 days with a change of fresh medium with hGFs every 3 days. For neural
differentiation, aggregates were resuspended with EB medium and transfered
to ULA plate. After 4 days in suspension culture, EBs were plated onto fibro-
nectin-coated plates (Falcon) in neural differentiation medium composed of
DMEM/F12 (GIBCO) with B27 and N2 supplements (GIBCO), 25 ng ml1
hEFG (R&D), 2.5 ng ml1 hIGF (R&D), 25 ng ml1 hPDGF-AA (R&D), and
8 ng ml1 bFGF. After 5 days under this condition, EBs were collected for
FACS analysis.
Hematopoietic Colony Forming Assay
Colony forming assay was performed by plating single-cell suspensions of
dissociated EBs intomethylcellulose H4230 (StemCell Technologies) as previ-
ously described (Chadwick et al., 2003). Briefly, EBs were dissociated with
collagenase B and cell dissociation buffer and then filtered with a 40 mm cell
strainer. Dissociated EBs were counted and plated at 10,000 cells into meth-
ylcellulose H4230 supplemented with recombinant human growth factors as
follows: 50 ng ml1 hSCF, 3 units ml1 hEPO (Amgen), 10 ng ml1 hGM-CSF
(Norvatis), and 10 ng ml1 hIL-3. Cells were incubated at 37C and 5% CO2
in humidified atmosphere. After incubation for 14 days, colonies were counted
based on morphological characteristics.
ChIP Analysis
A2B5+/ and c-KIT+/ subsets were sorted from H1 and H9 hESCs. Approxi-
mately 80,000 sorted cells were crosslinked using 1% formaldehyde. Chromatin
wasdigested inbuffercontaining0.1%SDStoobtain fragmentsofapproximately
of 500 bp length. Sonicated DNA was subjected to immunoprecipitation
using anti-trimethyl H3K4 (Abcam), anti-trimethyl H3K27 (Abcam), anti-rabbit
IgG, and anti-mouse IgG antibodies. Immunoprecipitated DNA was further
reverse crosslinked, purified, and subjected to quantitative PCR analysis using
Syber Green dye. Sequential ChIP was performed using established protocols
(Berstein et al., 2006). The sequences of the primers are listed in Table S2. To
calculate the relative enrichment, signals observed in control antibody were
subtracted from signals of specific antibody and then the resulting difference
was divided by signals observed from one fiftieth of ChIP input material.
Data Analysis
Data are presented as mean ± standard deviation (SD). p values were calcu-
lated using Student’s t test. p < 0.05 was considered as statistically significant;
*p < 0.05 and **p < 0.01.
SUPPLEMENTAL INFORMATION
Supplemental Information for this article includes six figures and two tables
and can be found with this article online at doi:10.1016/j.stem.2011.06.002.
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